Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 10—October 2005
Perspective

Antimicrobial Drug Resistance: "Prediction Is Very Difficult, Especially about the Future"1

Patrice Courvalin*Comments to Author 
Author affiliation: *Institut Pasteur, Paris, France

Main Article

Table

Predictable resistance types

Organism Resistance phenotype or mechanism
Streptococcus pneumoniae Penicillinase, gentamicin, glycopeptides
Streptococcus groups A, C, G Penicillins
Listeria monocytogenes Penicillins, gentamicin
Legionella pneumophila Macrolides, fluoroquinolones
Salmonella enterica serovar Typhi Third-generation cephalosporins
Haemophilus influenzae Third-generation cephalosporins
Neisseria meningitidis Third-generation cephalosporins
Brucella spp. Tetracyclines, rifampin, streptomycin
Clostridium difficile Glycopeptides
C. perfringens Penicillinase
Chlamydia spp. Tetracyclines

Main Article

1Niels Bohr.

Page created: February 22, 2012
Page updated: February 22, 2012
Page reviewed: February 22, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external